Search

Your search keyword '"Di Donato S."' showing total 115 results

Search Constraints

Start Over You searched for: Author "Di Donato S." Remove constraint Author: "Di Donato S." Database OpenAIRE Remove constraint Database: OpenAIRE
115 results on '"Di Donato S."'

Search Results

1. Pattern of recurrence and overall survival in esophagogastric cancer after perioperative FLOT and clinical outcomes in MSI-H population: the PROSECCO Study

2. Investigation of the skin contamination predictability by means of QForm UK extrusion code

3. Experimental analysis and modeling of the recrystallization behaviour of a AA6060 extruded profile

4. Investigation on the topological optimization of cooling channels for extrusion dies

5. Measurement of the Higgs boson production rate in association with top quarks in final states with electrons, muons, and hadronically decaying tau leptons at [Formula: see text]

6. A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the ‘BRAF BeCool’ study

7. 12 Group

8. Erratum to: Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy (The Oncologist, (2017), 22, 12, (1463-1469), 10.1634/theoncologist.2017-0158)

10. Suicidal ideation in a European Huntington's disease population

11. Are all people with diabetes and cardiovascular risk factors or microvascular complications at very high risk? Findings from the Risk and Prevention Study

12. The V471A polymorphism in autophagy-related gene ATG7 modifies age at onset specifically in Italian Huntington disease patients

13. Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from phase III TRIBE trial by the Gruppo Oncologico del Nord Ovest

15. Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY

16. NMDA receptor gene variations as modifiers in Huntington disease: a replication study

17. Cerebral and extracerebral cholesterol biosynthesis is impaired in HD patients

18. Observing Huntington's Disease: the European Huntington's Disease Network's REGISTRY

19. Normal and mutant HTT interact to affect clinical severity and progression in Huntington disease

25. Characterization of optic neuropathy in Friedreich Ataxia

27. N-3 fatty acids in patients with multiple cardiovascular risk factors

28. Evoluzione del gene Hdh nei primati

29. β-Defensin Genomic Copy Number Does Not Influence the Age of Onset in Huntington's Disease

30. COHORT study of the HSG. CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion

31. Population stratification may bias analysis of PGC-1alpha as amodifiewr of age at Huntington disease motor onset

32. Population stratification may bias analysis of PGC-1? as a modifier of age at Huntington disease motor onset

33. Discrepancies in reporting the CAG repeat lengths for Huntington's disease

35. NMDA receptor gene variations as modifiers in Huntington disease

38. EFNS guidelines on the molecular diagnosis of ataxias and spastic paraplegias

39. EFNS guidelines on the molecular diagnosis of channelopathies, epilepsies, migraine, stroke, and dementias

40. EFNS guidelines on the molecular diagnosis of channelopathies, epilepsies, migraine, stroke, and dementias: EFNS GUIDELINES/CME ARTICLE

41. EFNS guidelines on the molecular diagnosis of neurogenetic disorders: general issues, Huntington's disease, Parkinson's disease and dystonias

42. EFNS guidelines on the molecular diagnosis of mitochondrial disorders

44. EFNS guidelines on the molecular diagnosis of neurogenetic disorders: general issues, Huntington's disease, Parkinson's disease and dystonias

45. Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study

Catalog

Books, media, physical & digital resources